Active Ingredient (In Each Capsule)
Loperamide HCI 2 mg
The following Structured Product Label (SPL) was submitted to the FDA by Dolgencorp, Llc for the product Anti-diarrheal (NDC 55910-176). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each capsule), purpose, use, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Loperamide HCI 2 mg
Anti-diarrheal
controls symptoms of diarrhea, including Travelers' Diarrhea
Allergy alert: Do not use if you have ever had a rash or other allergic reaction to loperamide HCl
Heart alert: Taking more than directed can cause serious heart problems or death
taking antibiotics
tiredness, drowsiness, or dizziness may occur. Be careful when driving or operating machinery.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
butylated hydroxyanisole, edible ink, FD&C Blue #1, gelatin, glycerin, glyceryl caprylate, polyoxyl 40 hydrogenated castor oil, purified water
call toll free 1-866-309-9030
DGTMhealth
Compare to the active ingredient of Imodium® A-D*
Anti-Diarrheal
Liquid Softgels
Loperamide HCl Soft Gelatin Capsules, 2 mg
24 Softgels**
Actual Softgel Size
**Each Liquid-filled capsule contains 2 mg Loperamide HCl
THIS PRODUCT IS PACKAGED IN A CHILD-RESISTANT AND TAMPER EVIDENT PACKAGE. USE ONLY IF BLISTERS ARE INTACT.
KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.
*All trademarks are property of their respective owners. This product is not affiliated with the makers/owners of Imodium® A-D.
DISTRIBUTED BY
DOLGENCORP, LLC
100 MISSION RIDGE
GOODLETTSVILLE, TN 37072
MADE IN U.S.A
* Please review the disclaimer below.